Oncology & Cancer

Precision chemo-immunotherapy for pancreatic cancer?

Pancreatic cancer is highly lethal: according to the National Cancer Institute, only about 10 percent of patients remain alive five years after diagnosis. Now, a preclinical study from the lab of Marsha Moses, Ph.D. at Boston ...

Oncology & Cancer

Chemotherapy drug more effective when combined with microbubbles

Hepatocellular carcinoma is a particularly stubborn form of cancer with few treatments and a high mortality rate. It is usually treated by blocking the flow of blood to the tumor to induce cancer cell death. The common treatment, ...

Oncology & Cancer

New chimeric antibody that suppresses malignant cancers in dogs

Similar to humans, dogs live longer than before and an increasing number of them die from cancer. As seen in humans, dogs have malignant cancers that cannot be treated by existing therapies such as surgery, radiotherapy and ...

Oncology & Cancer

Study drug LOXO-101 shows tumor regression in varied cancers

A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a study led by The University of Texas MD Anderson Cancer Center.

Oncology & Cancer

Killer cocktail fights brain cancer

A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.

page 1 from 3